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Introduction
   Alzheimerʼs disease (AD) is the most common form of 
dementia in the elderly and it is characterized by progressive 
impairment in multiple cognitive domains of sufficient severity 
to interfere with individualsʼ daily living activities. Four 
articles in the Journal of Alzheimerʼs & Dementia in 2011 1 - 4)
described new criteria for AD dementia and mild cognitive 
impairment (MCI) due to the AD pathophysiological process 
(MCI due to AD) as well as their underlying rationale. These 
new criteria emphasize that the AD pathophysiological 
process starts years and perhaps decades prior to clinical 
symptoms, and that biomarkers can be used to detect amyloid 
beta (Aβ) deposition and the effects of neurodegeneration in 
the brain. These biomarkers include in vivo findings of brain 
imaging with positron emission tomography (PET) and 
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magnetic resonance imaging (MRI), imaging of amyloid plaques 
and biochemical assays of Aβ1-42, Aβ1-40, total tau and 
phosphorylated tau (p-tau) in the cerebrospinal fluid (CSF). 
However, these markers are not available at general hospitals. 
　In the present study, we investigated the effect of aging on 
the cerebral blood flow (CBF) measured using N-isopropyl- 
p-[(123)I]iodoamphetamine (123I-IMP) single-photon emission 
computed tomography (SPECT) in cognitively normal subjects 
(NSs) and patients with AD or DLB and determined the 
preferred areas of hypoperfusion in these diseases. Finally, 




 The SPECT device used in this study was an Infinia 
Hawkeye 4, General Electronic Company, U.S.A, which had 
a rotating two-headed gamma camera with a fan beam 
collimator (64x64). The regional cerebral blood flow (rCBF) 
changes were acquired for 20 minutes, starting 30 minutes 
after the administration of 111 MBq of 123I-IMP.  
   The easy Z-score Imaging System (eZIS) 5), and Voxel-
based Stereotactic Extraction Estimation (vbSEE) 6) were 
used in this study for the quantitative assessment of brain 
SPECT images. We used the parameter “extent %” with the 
vbSEE software program, the extent of an abnormal region 
in each segment (proportion of the coordinates with a Z-value 
that exceeds the threshold value, among all coordinates 
within a segment). 
 We examined 2 indicators of decreased levels (20% and 
30% decrease) of the “extent %” in the level 3 of vbSEE 
software program to decide which “extent %” is appropriate 
for assessing hypoperfusion for a comparison between NSs 
and diseased patients. 
Materials
 We established a “forgetfulness outpatient clinic” in our hospital 
on May 1, 2000. Thereafter, the hospital was reconstructed, 
and the medical care was restarted on October 1, 2007, at 
which point the SPECT device was changed to an Infinia 
Hawkeye 4, General Electronic Company, USA. For this reason, 
we recruited subjects based on their medical records starting 
from October 1, 2007, until December 31, 2017. The number 
of patients who underwent the mini-mental examination test 
(MMSE) during this period was 8,566, among whom 4,850 
were new patients. We conducted SPECT examination in 
2,412 of the new patients. 
 A total of 1,232 patients were ultimately enrolled in this 
study, including 180 NSs, 148 patients with aMCI, 802 patients 
with AD, and 102 patients with DLB. 
　NSs and AD patients were divided into 4 groups according 
to age (50-59, 60-69, 70-79 and 80-89 years old), while 
aMCI and DLB patients were divided into 3 groups according 
to age (50-69, 70-79, and 80-89 years old) because of small 
number of patients who were 50-59 years old. 
 The clinical diagnosis of probable AD was made according 
to the National Institute of Neurological and Communicative 
Disorders and Stroke - Alzheimerʼs Disease and Related Disorders 
Association (NINCDS-ADRDA) criteria 7). aMCI was diagnosed 
according to the criteria of Petersen et al. 8). Probable DLB 
was diagnosed according to the criteria of McKeith et al.9, 10).
 The following subjects were excluded from the study: 
patients with AD who had MMSE scores of <14/30 and were 
associated with widespread leucoaraiosis, cerebral infarction, 
cerebral hemorrhaging and subarachnoid hemorrhaging; patients 
with non-amnestic MCI; patients with DLB who had MMSE 
scores of <14/30 and were associated with cerebral vascular 
diseases; patients with neurodegenerative diseases, such as 
multiple system atrophy, progressive supranuclear palsy and 
corticobasal syndrome; and patients with normal pressure 
hydrocephalus, severe diabetes mellitus and heart diseases.
Statistical analyses
 We used the IBM-SPSS v.24, (U.S.A) and StatMate v.5. 
(Atms, Tokyo, Japan) software programs for the data analyses. 
Descriptive data are reported as mean and Standard Deviation 
(SD) or as number and percentage. Differences between 
each disease were assessed with a one way ANOVA, followed 
by the Tukeyʼs test for pairwise comparison when ANOVA 
showed a significant difference.
 To estimate the predicative ability, the sensitivity and 
specificity of the different items were calculated.
Results
Subjects enrolled in this study
 The demographic data of NSs patients with AD, aMCI 
and DLB are listed in Table 1. As shown in these tables, most 
patients in our “forgetfulness outpatient clinic” were over 70 
years old.
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Determination of the prefered areas of hypoperfusion in AD 
patients
 We determined the preferred areas of hypoperfusion by 
analyzing the “extent %” in AD patients 50-69 years old, and 
selected the top 10 areas expressing the average “extent %” 
value (Table 2) presented in descending order: the angular 
gyrus, supramarginal gyrus, precuneus, superior occipital 
gyrus, inferior parietal lobule, middle temporal gyrus, superior 
parietal lobule, inferior temporal gyrus, superior temporal 
gyrus and posterior cingulate.
Determination of the cut-off value in NSs and the sensitivity, 
specificity and efficacy in AD patients
 We determined the preferred areas of hypoperfusion in NSs 
corresponding to the preferred areas obtained in AD patients 
according to the ages in order to determine whether an 
“extent %” of 20% or 30% or 1 or >2 lesions of hypoperfusion 
was most suitable as the cut-off value (Table 3, 4). The 
number of AD patients showing hypoperfusion and the 
sensitivity, specificity and efficacy at each cut-off value 
compared with the age- and area-mactched NSs were shown 
in Table 3. The sensitivity was lower while the specificity 
was higher with an “extent %” of 30% than with 20% and >2 
areas of hypoperfusion than with 1 for differenciating AD 
from NSs (Table 3). We therefore ultimately adopted an 
“extent %” of 20% and 2> hypoperfusion areas as the cut-off 
value in this quantitative analysis of SPECT images, as the 
respective sensitivity and specificity for differenciating AD 
patients from NSs were 84.2% and 78.9% for 50-59 years 
old, 91.8% and 70.0% for 60-69 years old, 76.0% and 75.6% 
for 70-79 years old and 53.2% and 71.4% for 80-89 years old. 
These results indicate that the sensitivity decreases with aging.
 The frequency of hypoperfusion areas in NSs using these 
cut-off values was 21.1% for 50-59 years old, 32.5% for 60-69 
Table 1. Demographic data of enrolled subjects
Age Number of subjects Sex  M/F
MMSE scores
mean±SD
NS 50-59  38  7/31 29.6±0.7
60-69  40 11/29 29.3±0.7
 50-69*  78 18/60 29.4±0.7
70-79  67 25/42 28.9±1.0
80-89  35 17/18 28.7±1.0
Total 180 60/120
AD 50-59  19  9/10 21.8±3.0
60-69  73 22/51 22.3±3.4
70-79 317 106/211 22.0±3.5
80-89 393 105/288 21.8±3.5
Total 802 242/560
aMCI 50-69  18 6/12 27.6±1.2
70-79  77 28/49 27.5±1.2
80-89  53 20/33 27.3±1.2
Total 148 54/94
DLB 50-69 　7 3/4 23.2±5.7
70-79  52 30/22 24.1±3.2
80-89  43 18/25 23.3±3.9
Total 102 50/52
* For comparison with aMCI and DLB patients
Table 2. Frequent areas of hypoperfusion in AD patients (age 50-69)




Superior Occipital Gyrus 29.21
Inferior Parietal Lobule 27.50
Middle Temporal Gyrus 26.95
Superior Parietal Lobule 24.88
Inferior Temporal Gyrus 21.94
Superior Temporal Gyrus 19.97
Posterior Cingulate 19.43
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years old, 31.3% for 70-79 years old and 28.6% for 80-89 years 
old, showing no significant difference among age groups. 
Determination of the prefered areas of hypoperfusion in DLB 
patients
 We determined the prefered areas of hypoperfusion by 
analyzing the “extent %” in 102 patients with probable DLB and 
selected the 10 main areas expressing the average “extent %” 
value (Table 5), presented in descending order: the angular 
gyrus, superior occipital gyrus, inferior occipital gyrus, middle 
occipital gyrus, supramarginal gyrus, cuneus, middle temporal 
gyrus, inferior temporal gyrus, precuneus, and lingual gyrus. 
The respective sensitivity and specificity in DLB patients 
compared with age- and hypoperfusion area-matched NSs were 
100% and 75.6% for 50-69 years old, 84.6% and 70.1% for 
70-79 years old and 81.4% and 77.1% for 80-89 years old 
(Table 6). The cut-off value obtained in the AD patients was 
used to calculate the sensitivity and specificity in DLB patients.
 In contrast to our findings in AD patients, the sensitivity in 
DLB patients did not decrease with age.
The sensitivity and specificity in aMCI patients
 The respective sensitivity and specificity in aMCI patients 
compared with age- and hypoperfusion area-matched NSs 
were 88.9% and 75.6% for 50-69 years old, 57.1% and 
68.7% for 70-79 years old and 30.2% and 71.4% for 80-89 
years old (Table 6). The sensitivity in aMCI patients was 
Table 3. Number of cases showing hypoperfusion areas in AD patients & sensitivity, specificity & efficaxy in each cut-off valuen 










50-59  19 over 1area  19 100.0% 65.8% over 1area  18 94.7% 81.6%
over 2area  16  84.2% 78.9% over 2area  15 78.9% 94.6%
60-69  73 over 1area  70  95.9% 50.0% over 1area  65 89.0% 70.0%
over 2area  67  91.8% 70.0% over 2area  62 84.9% 87.5%
70-79 317 over 1area 271  85.5% 59.0% over 1area 234 73.1% 61.2%
over 2area 241  76.0% 75.6% over 2area 198 62.5% 85.1%
80-89 393 over 1area 266  67.7% 60.0% over 1area 208 52.9% 68.6%
over 2area 209  53.2% 71.4% over 2area 139 35.4% 85.7%
Table 4. Number of cases showing hypoperfusion areas in normal subjects age- 










50-59 38 over 1area 13 over 1area 7
over 2area 8 over 2area 2
60-69 40 over 1area 19 over 1area 12
over 2area 13 over 2area 5
50-69 78 over 1area 32 over 1area 18
over 2area 21 over 2area 6
70-79 67 over 1area 32 over 1area 26
over 2area 21 over 2area 10
80-89 35 over 1area 14 over 1area 11
over 2area 10 over 2area 5
Table 5. Prefered areas of hypoperfusion in DLB patients
Brain areas Average extent %
Angular Gyrus 40.44
Superior Occipital Gyrus 35.75
Inferior Occipital Gyrus 27.43
Middle Occipital Gyrus 27.26
Supramarginal Gyrus 24.26
Cuneus 23.98
Middle Temporal Gyrus 23.87
Inferior Temporal Gyrus 22.06
Precuneus 20.34
Lingual Gyrus 20.09
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considerably lower than in AD patients > 70 years old.
The comparison of the preferred areas of hypoperfusion in 
AD and DLB patients
 The top 10 areas of hypoperfusion in AD and DLB were 
shown based on the degree of hypoperfusion (Figure 1). 
Although there was a difference in the degree of hypoperfusion, 
6 of the top 10 areas with hypoperfusion showed a common 
decrease in AD and DLB patients. Hypoperfusion in the 
superior and inferior parietal lobules, precuneus and posterior 
cingulate suggests a greater likelihood of AD, while that in 
the middle and inferior occipital gyruses, cuneus, and lingual 
gyrus suggests a greater likelihood of DLB. 
 We counted the total number of hypoperfusion areas 
(maximum number is 20) observed in the top 10 areas of 
hypoperfusion with an “extent %” over  20%, regardless of 
the “extent %” in AD and DLB patients (Fig. 2 and 3).
Table 6. Sensitivity and specificity in aMCI, AD, and DLB patients compared with 
age- and hypoperfusion area-matched normal subjects
Disease Age No of cases sensitivity specificity
MCI 50-69  18 88.9% 75.6%
70-79  77 57.1% 68.7%
80-89  53 30.2% 71.4%
AD 50-59  19 84.2% 78.9%
60-69  73 91.8% 70.0%
70-79 317 76.0% 75.6%
80-89 393 53.2% 71.4%
DLB 50-69  7 100% 75.6%
70-79  52 84.6% 70.1%
80-89  43 81.4% 77.1%
Area of hypoperfusion                                     Diseases 





Superior Temporal Gyrus 
Middle Temporal Gyrus 
Inferior Temporal Gyrus 
Angular Gyrus 
Supramarginal Gyrus 
Inferior Parietal Lobule 
Superior Parietal Lobule 
Precuneus 
Posterior Cingulate 
Superior Occipital Gyrus 
Inferior Occipital Gyrus 
Middle Occipital Gyrus 
Cuneus 
Lingual Gyrus 
Figure 1. The top 10 areas of hypoperfusion in AD patients and DLB patients. Six of the top 10 hypoperfusion 
areas showed a common decrease in AD and DLB patients. Hypoperfusion in the superior and inferior 
parietal lobules, precuneus, and posterior cingulate suggests a greater likelihood of AD, while that in the 
middle and inferior occipital gyruses, cuneus and lingual gyrus suggests a greater likelihood of DLB.
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Figure 2. and 3. The distribution of the total number of hypoperfusion areas in AD (Fig.2) and DLB (Fig.3). AD showed a 
decrease in the high frequency total number of hypoperfusion in older groups, While no such findings were observed in DLB. 
N:Normal subjects, AD: Alzheimerʼs disease, DLB: dementia with Lewy bodies
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 The distribution of these number in AD patients showed a 
decrease of high frequency number of hypoperfusion in 
older age groups, while such findings were not observed in 
DLB patients. 
Effects of hypoperfusion of SPECT images on progression of 
aMCI and AD 
 In aMCI patients, while the number of cases was small, 
the 1-year change in the MMSE was -2.38±2.02 (n=16) in 
patients with abnormal SPECT images, and -0.67±1.81 
(n=18) in those with normal SPECT images (P<0.02, Mann-
Whitney test). Eight of 16 patients with abnormal SPECT 
images eventually developed AD, while 2 of 18 with normal 
SPECT images eventually developed AD.  Although only a 
small number of cases could be followed, the MMSE scores 
decreased over time in all AD patients regardless of the 
normality of their SPECT findings, but the progression in 
those with normal findings was one year slower than in those 
with abnormal findings (Fig. 4). 
Figure 4. Effects of hypoperfusion of SPECT images on progression of AD. The 
MMSE scores decreased with the passage of time in both AD patients with abnormal 
SPECT findings as well as in those with normal SPECT findings, although the 
progression in the latter was about one year slower than that in the former.
SP: SPECT
Discussion
 Recently, there have been developments in brain imaging 
techniques for detecting the core histological features of 
Alzheimer disease, j.e. amyloid plaques and neurofibrillary 
tangles. However, the utility of these techniques is still being 
investigated.
 Functional imaging methods, such as 18F-fluorodeoxyglucose 
[18F-FDG]- PET and perfusion (hexamethylpropyleneamine 
oxime [HMPAO]) SPECT are advocated as useful for clarifying 
the diagnosis of dementia when doubt remains. Although 
specific imaging ligands for amyloid are becoming available, 
the mainstay of functional brain imaging for the differential 
diagnosis of dementia will remain 18F-FDG-PET and blood 
flow SPECT even in general hospitals. 
Aging effects of hypoperfuion in NSs
 When analyzing the rCBF in patients with neurodegenerative 
diseases, we need to pay attention to age-related changes in 
the rCBF. There have been many reports describing the age-
related changes in the rCBF in normal subjects, although the 
main sites of a reduced rCBF have differed among studies. 
Indeed, several reports described the anterior cingulate as 
the main site within which the rCBF is reduced with normal 
aging11-15), while others failed to demonstrate any marked 
reduction in the rCBF in this area16, 17). Mozley et.al reported 
that the reduction in the rCBF was negligible in subjects >40 
years of age18). These discrepancies may be attributable to 
differences in the criteria used to select subjects and the 
diversity of the image analysis methods. 
 In the present study, we first determined the preferred 
98 Makiko Seto et al.: SPECT in AD & DLB
areas of hypoperfusion in AD and DLB patients. Although 
the degree of hypoperfusion differed, 6 of the 10 main areas 
of hypoperfusion showed a common decrease in AD and 
DLB patients. Hypoperfusion in the superior and inferior 
parietal lobules, precuneus and posterior cingulate suggests 
a greater likelihood of AD, while that in the middle and 
inferior occipital gyruses, cuneus and lingual gyrus suggests 
a greater likelihood of DLB. 
 Based on these results, the frequency of hypoperfusion in 
NSs corresponding to the preferred areas of hypoperfuion 
for AD and DLB was investigated. Our findings indicated no 
marked difference in the degree of hypoperfusion with age 
in NSs. 
Sensitivity and specificity of SPECT imaging for diagnosing 
dementia
 Studies of the accuracy of SPECT for diagnosing AD 
reported sensitivities of 65%-85% and specificities of 72%-
87%19). Studies for 18F-FDG PET generally reported higher 
accuracy, with sensitivities of 75%-99% and specificities of 
71%-93% for AD20). OʼBrien et al.21) reported that when 
performing a visual rating, the key imaging features were a 
reduced uptake in the precuneus and lateral parietal lobes in 
both AD and DLB, the relative preservation of the posterior 
cingulate in DLB, and a more extensive occipital loss in 
DLB, with a reduced uptake in the temporal and frontal lobe 
being more likely in AD than DLB. The consensus diagnosis 
with 18F-FDG PET was superior to that with SPECT for both 
dementia vs. no-dementia and AD vs. DLB comparisons. 
The sensitivity and specificity for dementia/no-dementia was 
85% and 90%, respectively, for 18F-FDG PET and 71% and 
70%, respectively, for SPECT. The authors recommended 
that 18F-FDG PET should be performed instead of perfusion 
SPECT for the differential diagnosis of degenerative dementia 
if functional imaging was indicated. There have been no 
reports on the age-related incidence of hypoperfusion on 
SPECT images in AD patients.
 In the present study, the respective sensitivity and specificity 
for differenciating AD from NSs were 84.2% and 78.9% for 
50-59 years old, 91.8% and 70.0% for 60-69 years old, 
76.0% and 75.6% for 70-79 years old and 53.2% and 71.4% 
for 80-89 years old. These results indicate that sensitivity 
decreases with aging. The results in aMCI were the same as 
those in AD; however, in DLB patients, no marked decreese 
in the sensitivity with aging was observed. While this degree 
of diagnostic accuracy might still be clinically helpful when 
comparing dementia and no-dementia patients, the accuracy 
for differentiating AD from DLB was disappointingly poor13). 
Our finding that 6 of the 10 main areas of hypoperfusion 
showed a common decrease in AD and DLB patients indicates 
that clear discrimination between AD and DLB is difficult.
 To this end, cardiac MIBG scintigraphy is much more 
useful than SPECT22). 
 The present study showed that for differentiating AD 
patients from NSs, SPECT findings were very useful, particularly, 
among patients <69 years old. Why the sensitivity in aged 
AD patients, particularly those over 80 years old, was 
decreased is not clear. The mechanism involving a decreese 
of rCBF in aged person described in the previous reports is 
not considered to be aging effects. 
 Argyrophilic grain disease (AGD) is said to be the second-
most common neurodegenerative disease that causes dementia 
in the elderly after AD23-25). Neuropathologic changes due to 
AGD may be found in isolation or in association with other 
neurodegenerative disorders, such as AD, Pickʼs disease, 
progressive supranuclear palsy (PSP), corticobasal degeneration 
(CBD), Parkinsonʼs disease, TDP-43 proteinopathies, DLB 
and multiple system atrophy. Braak et al. reported that patients 
81-85 years old had the highest frequency of AGD (40/125 
cases), whereas only 5 patients <60 years old were found to 
have argyrophilic grains on a post-mortem examination24). 
To date, no study has been able to demonstrate a distinct 
clinical syndrome associated with AGD. The diagnosis is 
exclusively based on postmortem findings and no reports on 
SPECT findings have been published. 
 Senile dementia of the neurofibrillary tangle (SD-NFT) 
type is a subset of dementia that primarily occurs in the 
oldest old patients26, 27). Although SD-NFT is not considered 
very rare in senile dementia patients, most SD-NFT cases 
are probably clinically misdiagnosed as AD in the absence 
of a post-mortem pathological investigation.
 These two diseases are clinically impossible to definitely 
diagnose. We were therefore unable to exclude the possibility 
that these diseases were present in the aged group of AD 
patients in our study, which might have reduced the sensitivity 
in that population.
Prefered areas of hypoperfusion among disease
 The pattern of SPECT hypoperfusion and PET hypometabolism 
usually seen AD patients involves the anterior medial temporal 
lobes, the posterior cingulate and posterior temporoparietal 
cortex28-30), Some neuroimaging features of DLB have been 
proposed to enhance the diagnostic accuracy. Indeed, occipital 
hypometabolism on 18F-FDG-PET images is a useful biomarker 
for differentiating DLB from AD31, 32).
 In the present study, we determined the top 10 preferred 
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areas of hypoperfusion using the vbSEE software program. 
Despite a marked difference in the hypoperfusion degree, 6 
of the top 10 hypoperfusion areas showed a common decrease 
in AD and DLB patients. Hypoperfusion in the superior and 
inferior parietal lobules, precuneus and posterior cingulate 
suggests a greater likelihood of AD, while that in the middle 
and inferior occipital gyruses, cuneus and lingual gyrus 
suggests a greater likelihood of DLB. 
 The pathological hallmarks of DLB are the presence of 
Lewy bodies and Lewy neurites, but many cases also display 
an AD pathology postmortem33, 34). However, the importance 
of concurrent AD pathology in DLB, at what point during 
the disease it occurs and its relationships to the clinical 
presentations are unclear35). Considering the previous reports 
that AD pathology occurs in many cases of DLB, it seems 
natural for the areas of hypoperfusion to overlap between 
AD and DLB cases. The cingulate island sign (CIS) on FDG-
PET and brain perfusion SPECT was recently proposed as a 
neuroimaging feature of DLB. This term references the sparing 
of the posterior cingulate cortex relative to the precuneus 
plus cuneus and this sign is extremely specific for an accurate 
diagnosis of DLB36, 37). The CIS is influenced by concomitant 
AD-type neurofibrillary tangle (NFT) pathology and gradually 
disappears as DLB progresses38). In the present study, the 
decreased perfusion in the posterior cingulate in DLB was 
ranked 16th indicating that posterior cingulate hypoperfusion 
is not an important finding in the diagnosis of DLB. 
Prediction of conversion from aMCI to AD
 The concept of MCI is now widely accepted and continues 
to receive substantial attention in the literature, as it represents 
a possible treatment target for AD. Its predictive power is 
reflected in annual conversion rates of up to 15% from MCI 
to AD, compared to conversion rates of 1%-2% from normal 
aging to AD39, 8).  SPECT has been reported to be valuable for 
predicting the progression from MCI to AD-dementia40-43). 
However, differences in the methods of analyzing SPECT 
images among groups have hindered the comparison of our 
results with those of previous reports. Our study clearly showed 
that 50% of aMCI patients with abnormal SPECT findings 
showed rapid regression of the cognitive function compared 
to those with normal findings. Identifyiung such at-risk 
patients at an early time point would enable early intervention 
and a timely start of treatment, possibly preventing disease 
progression altogether.
Conclusion
 A quantitative SPECT image analysis showed sensitivity 
and specificity equivalent to those of FDG-PET in AD 
patients 50-69 years old, suggesting its utility for making an 
AD diagnosis. A quantitative SPECT image analysis was 
also shown to be a useful auxiliary diagnostic technique for 
diagnosing DLB.
 Six of the top 10 preferred areas of hypoperfusion were 
shared between AD and DLB. Hypoperfusion in the superior 
and inferior parietal lobules, precuneus and posterior cingulate 
suggests a greater likelihood of AD, while that in the middle 
and inferior occipital gyruses, cuneus and lingual gyrus 
suggests a greater likelihood of DLB. Although FDG-PET 
performs better than perfusion SPECT, our study confirms 
the utility of perfusion SPECT as a valid alternative when 
FDG-PET is unavailable.
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